Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Rigel Pharmaceuticals Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 118 | 1 | 106 | −11 |
| Shares | 110.6M | 10.0K | 106.3M | −4.37M (−3.9%) |
| Value | $142.7M | $12.9K | $114.8M | −$28.0M (−19.6%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 36,017 | $38.9K | 0.00% |
| SG Americas Securities, LLC | 31,493 | $34.0K | 0.00% |
| GTS Securities LLC | 13,203 | $14.3K | 0.00% |
| Creative Planning | 11,753 | $12.7K | 0.00% |
| HighTower Advisors, LLC | 10,154 | $11.0K | 0.00% |
| Group One Trading, L.P. | 4,980 | $5.38K | 0.00% |
Sold out (17)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tamarack Advisers, LP | 1,250,000 | $1.61M |
| Putnam Investments LLC | 255,730 | $329.9K |
| Rhenman & Partners Asset Management AB | 253,832 | $327.4K |
| Cubist Systematic Strategies, LLC | 101,240 | $130.6K |
| Verition Fund Management LLC | 89,235 | $115.1K |
| Virtu Financial LLC | 50,288 | $65.0K |
| Visionary Wealth Advisors | 22,297 | $28.8K |
| Squarepoint Ops LLC | 19,929 | $25.7K |
| HRT Financial LP | 14,854 | $19.0K |
| Alpine Global Management, LLC | 12,868 | $16.6K |
| Bank of Montreal | 10,073 | $16.2K |
| Schonfeld Strategic Advisors LLC | 12,000 | $15.5K |
| Point72 Middle East FZE | 11,026 | $14.2K |
| GWM Advisors LLC | 1,000 | $1.29K |
| Worth Asset Management, LLC | 1,000 | $1.29K |
| Column Capital Advisors, LLC | 310 | $400 |
| CWM, LLC | 87 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| BerganKDV Wealth Management, LLC | 10,000 | $12.9K |